Phase II Trial of Gemcitabine and an Omega-3 Rich Lipid Infusion in Advanced Pancreatic Cancer

被引：0
|
作者：
Arshad, A. [1 ]
Hall, T. [1 ]
Al-Leswas, D. [1 ]
Bilku, D. [1 ]
Cairns, V. [1 ]
Mann, C. [1 ]
Morgan, B. [1 ]
Metcalfe, M. [1 ]
Steward, W. P. [1 ]
Dennison, A. R. [1 ]
机构：
[1] Univ Hosp Leicester, Leicester, Leics, England
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)71910-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S471 / S471
页数：1
相关论文
共 50 条
  • [1] Gemcitabine in advanced pancreatic cancer: A phase II trial
    Crino, L
    Mosconi, AM
    Calandri, C
    Corgna, E
    Darwish, S
    Tonato, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1266 - 1266
  • [2] Gemcitabine in advanced pancreatic cancer -: A phase II trial
    Crinò, L
    Mosconi, AM
    Calandri, C
    Corgna, E
    Porrozzi, S
    Chiara, S
    Nobili, MT
    Tonato, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (03): : 296 - 298
  • [3] Restoration of Activity in Mannose-binding Lectin Complement Pathway in Patients With Advanced Pancreatic Cancer Treated With Intravenous Omega-3 Rich Lipid Infusion and Gemcitabine is Associated With Improved Outcome
    Arshad, A.
    Chung, W. Y.
    Al-Leswas, D.
    Hall, T.
    Bilku, D.
    Pollard, C.
    Metcalfe, M.
    Steward, W. P.
    Dennison, A. R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S445 - S445
  • [4] Cellular and plasma uptake of parenteral omega-3 rich lipid emulsion fatty acids in patients with advanced pancreatic cancer
    Arshad, A.
    Chung, W. Y.
    Isherwood, J.
    Mann, C. D.
    Al-Leswas, D.
    Steward, W. P.
    Metcalfe, M. S.
    Dennison, A. R.
    CLINICAL NUTRITION, 2014, 33 (05) : 895 - 899
  • [5] A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
    Choi, Jong Gwon
    Seo, Jae Hong
    Oh, Sang Cheul
    Choi, Chul Won
    Kim, Jun Suk
    CANCER RESEARCH AND TREATMENT, 2012, 44 (02): : 127 - 132
  • [6] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    Hwang, In Gyu
    Jang, Joung-Soon
    Oh, Sung Yong
    Lee, Suee
    Kwon, Hyuk Chan
    Lee, Gyeong Won
    Go, Seil
    Kang, Myoung Hee
    Cha, Young Joo
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2371 - 2376
  • [7] Phase II trial of bevacizurnab plus gemcitabine in patients with advanced pancreatic cancer
    Kindler, HL
    Friberg, G
    Singh, DA
    Locker, G
    Nattam, S
    Kozloff, M
    Taber, DA
    Karrison, T
    Dachman, A
    Stadler, WM
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 8033 - 8040
  • [8] Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial
    Vittorio Ferrari
    Francesca Valcamonico
    Vito Amoroso
    Edda Simoncini
    Lucia Vassalli
    Patrizia Marpicati
    Giovanni Rangoni
    Salvatore Grisanti
    Guido AM Tiberio
    Franco Nodari
    Carla Strina
    Giovanni Marini
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 185 - 190
  • [9] Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial
    Ferrari, V
    Valcamonico, F
    Amoroso, V
    Simoncini, E
    Vassalli, L
    Marpicati, P
    Rangoni, G
    Grisanti, S
    Tiberio, GAM
    Nodari, F
    Strina, C
    Marini, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (02) : 185 - 190
  • [10] Phase II Trial of Gemcitabine, Irinotecan, and Celecoxib in Patients With Advanced Pancreatic Cancer
    Lipton, Allan
    Campbell-Baird, Cynthia
    Witters, Lois
    Harvey, Harold
    Ali, Suhail
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (04) : 286 - 288
12345